Clarivate CLVT Life Sciences & Healthcare — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Clarivate in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Clarivate’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clarivate's life sciences & healthcare — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Clarivate's life sciences & healthcare — revenue?
- Clarivate (CLVT) reported life sciences & healthcare — revenue of $93.3M in Q1 2026.
- How has Clarivate's life sciences & healthcare — revenue changed year-over-year?
- Clarivate's life sciences & healthcare — revenue decreased by 5.1% year-over-year, from $98.3M to $93.3M.
- What is the long-term trend for Clarivate's life sciences & healthcare — revenue?
- Over 3 years (2022 to 2025), Clarivate's life sciences & healthcare — revenue has grown at a -4.9% compound annual growth rate (CAGR), from $452.6M to $389.8M.
- What does life sciences & healthcare — revenue mean?
- This represents the total gross income generated by the Life Sciences & Healthcare segment from its data, software, and workflow solutions. It serves as a primary indicator of the segment's market demand and its ability to monetize its specialized information services within the healthcare and life sciences industries.